Nevakar featured in Tech News

Dr. Puri's first venture, InnoPharma, was founded in 2005 with a focus on developing complex generic pharmaceuticals of sterile injectable dose forms.  This was sold to Pfizer in 2014.  Puri went on to found Nevakar, which is a specialty pharmaceutical...


Nevakar Featured in Global Business Reports

You previously had great success with InnoPharma, which was eventually sold to Pfizer. Could you provide some insight into your new venture, Nevakar? InnoPharma’s acquisition was a strategic move by Pfizer; its product pipeline and track record of successfully developing...


Mayor Hayes Attends Nevakar’s One Year Anniversary Celebration

BRIDGEWATER, N.J., November, 2016 On Wednesday, October 12th, I had the pleasure of attending the One Year Anniversary Celebration of an innovative, new drug company, Nevakar at the NJ Center of Excellence in our Township. Nevakar is a specialty pharmaceutical company,...


Nevakar Announces $55 Million Fundraising / Press Release

BRIDGEWATER, NJ, July 27, 2016 – Nevakar LLC, a privately-held specialty pharmaceutical company developing innovative products focused on therapies within the injectable and ophthalmic space, today announced that it has raised $55 million. Proceeds from the financing will be used...


BioNJ welcomes new Innovation Member: Nevakar, LLC

In this quarterly Member Update, we are pleased to recognize our new and returning Members. Your investment in Membership is an investment in yourself, your organization and New Jersey's vibrant life sciences ecosystem...


Nevakar / Advance Realty Press Release

Advance Realty and CrossHarbor Capital Partners Ink Another Dynamic Tenant at the New Jersey Center of Excellence With 26,500 SF Lease of Lab and Office Space, Bio-Pharma Start-Up Nevakar LLC Represents Latest Addition to Bridgewater Campus's Tenant Roster Company Selects...